The use of thalidomide in the management of bleeding from a gastric cancer.
- September 22, 2014
- Support Groups
Abstract: Medical management of severe gastrointestinal bleeding can present a therapeutic challenge. This article describes a case of bleeding secondary to gastric cancer that failed to settle, despite treatment with tranexamic acid, etamsylate and sucralfate. Thalidomide was prescribed for its antiangiogenic properties. Bleeding settled within 1 week of starting 300 mg of thalidomide nocte.
Jul2009, Vol. 23 Issue 5, p473-475, 3p
Lambert, K. and Ward, J.